ReviewTherapeutic advances in chronic disease2019

Stromal cell-derived factor-1 as a potential therapeutic target for osteoarthritis and rheumatoid arthritis.

Robert Bragg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.